miR-133b Down-Regulates ABCC1 and Enhances the Sensitivity of CRC to Anti-Tumor Drugs

Oncotarget - United States
doi 10.18632/oncotarget.17677
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells

OncoTargets and Therapy
OncologyPharmacology
2020English

miR-122 Regulates Hepatic Lipid Metabolism and Tumor Suppression

Journal of Clinical Investigation
Medicine
2012English

MiR-221 Negatively Regulates Innate Anti-Viral Response

PLoS ONE
Multidisciplinary
2018English

MiR-15a/16 Deficiency Enhances Anti-Tumor Immunity of Glioma-Infiltrating CD8+ T Cells Through Targeting mTOR

International Journal of Cancer
Cancer ResearchOncology
2017English

Simultaneous Downregulation of miR-21 and Upregulation of miR-7 Has Anti-Tumor Efficacy

Scientific Reports
Multidisciplinary
2020English

Anti-Vegfr2 Therapy Delays Growth of Preclinical Pediatric Tumor Models and Enhances Anti-Tumor Activity of Chemotherapy

Oncotarget
Oncology
2019English

miR-514a Regulates the Tumour Suppressor NF1 and Modulates BRAFi Sensitivity in Melanoma

Oncotarget
Oncology
2015English

The Development of Novel Organotin Anti-Tumor Drugs: Structure and Activity

Metal-Based Drugs
1998English

Anti Sense DNA Down-Regulates Proteins Kinase C-Epsilon and Enhances Vasopressin-Stimulated Na+ Absorption in Rabbit Cortical Collecting Duct.

Journal of Clinical Investigation
Medicine
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy